These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma. Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606 [TBL] [Abstract][Full Text] [Related]
3. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Puleo CA; Coventry BJ; Kashani-Sabet M; Smithers BM; Paul E; Kraybill WG; McKinnon JG; Wang HJ; Elashoff R; Faries MB; N Engl J Med; 2014 Feb; 370(7):599-609. PubMed ID: 24521106 [TBL] [Abstract][Full Text] [Related]
4. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases. Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828 [TBL] [Abstract][Full Text] [Related]
5. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755 [TBL] [Abstract][Full Text] [Related]
6. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma. Caracò C; Marone U; Celentano E; Botti G; Mozzillo N Ann Surg Oncol; 2007 Sep; 14(9):2662-7. PubMed ID: 17597345 [TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study. Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169 [TBL] [Abstract][Full Text] [Related]
8. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3). Nowecki ZI; Rutkowski P; Michej W Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535 [TBL] [Abstract][Full Text] [Related]
9. Patterns of recurrence and survival after lymphadenectomy in melanoma patients: clarifying the effects of timing of surgery and lymph node tumor burden. Spillane AJ; Pasquali S; Haydu LE; Thompson JF Ann Surg Oncol; 2014 Jan; 21(1):292-9. PubMed ID: 24052314 [TBL] [Abstract][Full Text] [Related]
10. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study. Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935 [TBL] [Abstract][Full Text] [Related]
12. The optimum excision margin and regional node management for primary cutaneous T3 melanomas (2-4 mm in Thickness): a retrospective study of 1587 patients treated at a single center. Lamboo LG; Haydu LE; Scolyer RA; Quinn MJ; Saw RP; Shannon KF; Spillane AJ; Stretch JR; Bonenkamp JJ; Thompson JF Ann Surg; 2014 Dec; 260(6):1095-102. PubMed ID: 25072430 [TBL] [Abstract][Full Text] [Related]
16. The role of sentinel lymph node biopsy in patients with local recurrence or in-transit metastasis of melanoma. Gipponi M; Solari N; Giovinazzo D; Queirolo P; Bertoglio S; Villa G; Gualco M; Bleidl D; Cafiero F Anticancer Res; 2014 Jun; 34(6):3197-203. PubMed ID: 24922694 [TBL] [Abstract][Full Text] [Related]
18. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients]. de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183 [TBL] [Abstract][Full Text] [Related]
19. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma. Gyorki DE; Boyle JO; Ganly I; Morris L; Shaha AR; Singh B; Wong RJ; Shah JP; Busam K; Kraus D; Coit DG; Patel S Eur J Surg Oncol; 2014 Mar; 40(3):305-10. PubMed ID: 24361245 [TBL] [Abstract][Full Text] [Related]
20. Reevaluation of the locoregional recurrence rate in melanoma patients with a positive sentinel node compared to patients with palpable nodal involvement. Veenstra HJ; van der Ploeg IM; Wouters MW; Kroon BB; Nieweg OE Ann Surg Oncol; 2010 Feb; 17(2):521-6. PubMed ID: 19898903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]